A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
BioFire Diagnostics, a Utah company that develops and manufacturers instruments to identify pathogens, will receive a tax credit worth up to $24.4 million over the next 20 years conditioned upon it creating up to 657 jobs. The Salt Lake Tribune